Tools

LEADER 04205nam 22005178i 4500

001 ssj0001798062;

003 WaSeSS;

005 20220413120839.0;

006 m d ;

007 cr n ;

008 170307s2017 nju sb 001 0 eng d;

010 a| 2017010954;

020 a| 9781630913212 (paperback : alk. paper);

020 z| 9781630913229 (Epub);

020 z| 9781630913236 (Web);

035 a| (WaSeSS)ssj0001798062;

040 a| DNLM/DLCc| DLCd| DLCd| WaSeSS;

042 a| pcc;

049 a| EREEa| NEHH;

050 10 a| RE991b| .A58 2017;

060 10 a| WW 166;

082 00 a| 617.7/0612| 23;

245 00 a| Anti-VEGF use in ophthalmologyh| [electronic resource] /c| editors, Jay S. Duker, MD, Director, New England Eye Center, Professor and Chairman, Department of Ophthalmology, Tufts Medical Center, Tufts University School of Medicine, Boston, Massachusetts, Michelle C. Liang, MD, Assistant Professor Ophthalmology, New England Eye Center, Tufts Medical Center, Tufts University School of Medicine, Boston, Massachusetts.;

246 1 a| Anti-vascular endothelial growth factor use in ophthalmology;

260 a| Thorofare, NJ :b| SLACK Incorporated,c| [2017];

300 a| xiii, 222 pages :b| illustrations (chiefly color) ;c| 23 cm;

504 a| Includes bibliographical references and index.;

506 a| Available only to authorized users.;

520 a| "The introduction of anti-vascular endothelial growth factor (VEGF) agents has revolutionized therapy for a host of ocular diseases associated with leakage from normal blood vessels and pathologic blood vessel growth. Anti-VEGF Use in Ophthalmology is an all-inclusive reference designed to provide detailed, up-to-date, and clinically relevant information on the current use of anti-VEGF agents in the treatment of all ocular conditions. Drs. Jay S. Duker and Michelle C. Liang have assembled a prestigious group of contributors who pool their collective expertise in this comprehensive book. Anti-VEGF Use in Ophthalmology is split into two sections with the first providing the history of VEGF and an overview of anti-VEGF agents and different routes of drug delivery, as it is important for eye care providers to be familiar with up-to-date aspects of the medications and indications for use. The second section details the clinical uses of anti-VEGF agents in numerous ocular diseases, from the anterior segment including cornea and glaucoma to uveitis and various retinal and choroidal diseases. Each chapter in this section summarizes the disease process and utilizes high-quality ocular imaging to demonstrate the therapeutic use of the anti-VEGF agents. Anti-VEGF Use in Ophthalmology combines the theory and applications of anti-VEGF agents, making it not only a great learning tool for beginners but also a useful reference tool for a wide range of eye care professionals including optometrists, residents, comprehensive ophthalmologists, as well as specialists in anterior segment, pediatrics, and vitreoretinal disease"--Provided by publisher.;

538 a| Mode of access: World Wide Web;

650 12 a| Eye Diseasesx| drug therapy=| ^A920957;

650 22 a| Vascular Endothelial Growth Factor Ax| antagonists & inhibitors=| ^A1337441;

650 22 a| Angiogenesis Inhibitorsx| therapeutic use=| ^A1032955;

650 22 a| Neovascularization, Pathologicx| drug therapy=| ^A959996;

655 0 a| Electronic books.=| ^A491897;

700 1 a| Duker, Jay S.,d| 1958-=| ^A932163;

700 1 a| Liang, Michelle C.,d| 1983-?| UNAUTHORIZED;

856 40 z| Full text available from Ebook Central - Academic Completeu| https://ebookcentral.proquest.com/lib/eastcarolina/detail.action?docID=4854426;

949 a| CLICK ON WEB ADDRESSw| ASISh| JOYNER188;

949 a| CLICK ON WEB ADDRESSw| ASISh| HSL77;

949 a| CLICK ON WEB ADDRESSw| ASISh| JMUSIC60;

596 a| 1 3 4;

998 a| 5805570;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 5805570-1001l| JNETm| JOYNERr| Ys| Yt| JNESSBKu| 4/15/2022x| EBOOKz| JERESOURCE;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 5805570-2001l| HSLELECm| HSLr| Ys| Yt| HEBKu| 4/15/2022x| EBOOKz| HERESOURCE;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 5805570-3001l| MNETm| JMUSICr| Ys| Yt| MNESSBKu| 4/15/2022x| EBOOKz| JERESOURCE;

Anti-VEGF use in ophthalmology / editors, Jay S. Duker, MD, Director, New England Eye Center, Professor and Chairman, Department of Ophthalmology, Tufts Medical Center, Tufts University School of Medicine, Boston, Massachusetts, Michelle C. Liang, MD, Assistant Professor Ophthalmology, New England Eye Center, Tufts Medical Center, Tufts University School of Medicine, Boston, Massachusetts.

Other author	Duker, Jay S., 1958-
Other author	Liang, Michelle C., 1983-
Format	Electronic
Publication Info	Thorofare, NJ : SLACK Incorporated, [2017]
Description	xiii, 222 pages : illustrations (chiefly color) ; 23 cm
Supplemental Content	Full text available from Ebook Central - Academic Complete
Subjects	Eye Diseases--drug therapy. Vascular Endothelial Growth Factor A--antagonists & inhibitors. Angiogenesis Inhibitors--therapeutic use. Neovascularization, Pathologic--drug therapy.

Variant title	Anti-vascular endothelial growth factor use in ophthalmology
Abstract	"The introduction of anti-vascular endothelial growth factor (VEGF) agents has revolutionized therapy for a host of ocular diseases associated with leakage from normal blood vessels and pathologic blood vessel growth. Anti-VEGF Use in Ophthalmology is an all-inclusive reference designed to provide detailed, up-to-date, and clinically relevant information on the current use of anti-VEGF agents in the treatment of all ocular conditions. Drs. Jay S. Duker and Michelle C. Liang have assembled a prestigious group of contributors who pool their collective expertise in this comprehensive book. Anti-VEGF Use in Ophthalmology is split into two sections with the first providing the history of VEGF and an overview of anti-VEGF agents and different routes of drug delivery, as it is important for eye care providers to be familiar with up-to-date aspects of the medications and indications for use. The second section details the clinical uses of anti-VEGF agents in numerous ocular diseases, from the anterior segment including cornea and glaucoma to uveitis and various retinal and choroidal diseases. Each chapter in this section summarizes the disease process and utilizes high-quality ocular imaging to demonstrate the therapeutic use of the anti-VEGF agents. Anti-VEGF Use in Ophthalmology combines the theory and applications of anti-VEGF agents, making it not only a great learning tool for beginners but also a useful reference tool for a wide range of eye care professionals including optometrists, residents, comprehensive ophthalmologists, as well as specialists in anterior segment, pediatrics, and vitreoretinal disease"--Provided by publisher.
Bibliography note	Includes bibliographical references and index.
Access restriction	Available only to authorized users.
Technical details	Mode of access: World Wide Web
Genre/form	Electronic books.
LCCN	2017010954
ISBN	9781630913212 (paperback : alk. paper)

Availability

Library	Location	Call Number	Status	Item Actions
	Electronic Resources	Access Content Online	✔ Available

Click here for more information about this title

Availability